Description
About Vonolex-20
Vonolex-20 contains Vonoprazan Fumarate 20 mg, a novel potassium-competitive acid blocker or P-CAB, representing a newer class of acid-suppressing therapy beyond conventional proton pump inhibitors. As gastroenterologists and physicians increasingly look for faster, more reliable acid control options, Vonoprazan positions Vonolex-20 as a next-generation digestive health product rather than a standard PPI, giving franchise partners genuine first-mover advantage in a therapeutic category that’s still gaining wider prescriber adoption in India.
How It Works
Vonoprazan works by competitively blocking potassium binding at the gastric proton pump, offering a distinct mechanism compared to traditional PPIs. Published research shows that, compared with proton pump inhibitors, it delivers faster onset of action, stronger acid suppression and a longer duration of effect. Its longer half-life means efficacy is sustained over an extended period, which helps reduce daily dosing frequency, an advantage that supports better patient compliance in long-term acid management.
Indications
- Hyperacidity
- Reflux esophagitis
- Acid-related disorders
Why Source Vonolex-20 from Lxir
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. A newer-generation molecule like Vonoprazan requires precise formulation to deliver consistent potency and reliable onset of action and Vonolex-20 is manufactured under strict quality control to maintain this reliability across every batch. For a PCD pharma franchise company in India, sourcing an early-entry P-CAB product gives franchise partners a genuine edge with gastroenterologists and physicians looking to move beyond standard PPI therapy, backed by complete promotional support through our PCD pharma franchise division.
Frequently Asked Questions
How is Vonoprazan different from standard PPIs?
Vonoprazan is a potassium-competitive acid blocker (P-CAB), a distinct mechanism from proton pump inhibitors, offering faster onset, stronger and longer-lasting acid suppression based on published research.
What conditions is Vonolex-20 used for?
It is indicated for hyperacidity, reflux esophagitis and other acid-related digestive disorders.
Does this reduce how often the medicine needs to be taken?
Due to its longer half-life, its efficacy is sustained over time, which can help reduce daily dosage frequency compared to some conventional options.
What pack size is available?
Vonolex-20 is supplied in a 10 x 10 tablet pack.
Bulk Order & Manufacturing Enquiry
Pharmaceutical distributors, gastroenterology-focused chemists and franchise partners interested in bulk ordering, third-party manufacturing or adding Vonolex-20 to their digestive health portfolio can connect with Lxir Medilabs through our PCD pharma franchise division for pricing, minimum order details and territory availability across India.
Disclaimer: This is a prescription product and should be used strictly under the supervision of a registered medical practitioner.
